Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000552366 | SCV000622543 | likely benign | Ataxia-telangiectasia syndrome | 2024-08-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000567462 | SCV000665605 | likely benign | Hereditary cancer-predisposing syndrome | 2022-08-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Baylor Genetics | RCV003464122 | SCV004207054 | uncertain significance | Familial cancer of breast | 2023-10-06 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003464122 | SCV005082068 | likely benign | Familial cancer of breast | 2024-05-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |